CTLA4 ligation attenuates AP-1, NFAT and NF-κB activity in activated T cells

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 838-844

  Fraser, J Henry ^a   Rincón, Mercedes ^b   McCoy, Kathy D ^a,c   Gros, Graham Le ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b UNIVERSITY OF VERMONT   (United States)

^c INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

CTLA4; Nuclear transcription factor; T cell activation

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033048961     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199903)29:03<838::aid-immu838>3.0.co;2-p     Document Type: Article

References (32)

1. Cockerill, P. N., Shannon, M. F., Bert, A. G., Ryan, G. R. and Vadas, M. A., The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc. Natl. Acad. Sci. USA 1993. 90: 2466-2470.
2. Goldfield, A. E., McCaffrey, P. G., Strominger, J. L. and Rao, A., Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter. J. Exp. Med. 1993. 178: 1365-1379.
3. Rooney, J. W., Hoey, T. and Glimcher, L. H., Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity 1995. 2: 473-483.
4. Tsytsykova, A. V., Tsitsikov, E. N. and Geha, R. S., The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J. Biol. Chem. 1996. 271: 3763-3770.
5. Rao, A., NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 1994. 15: 274-281.
6. Kopp, E. B. and Ghosh, S., NF-(greek small letter script kappa)B and rel proteins in innate immunity. Adv. Immunol. 1995. 58: 1-27.
7. Rao, A., Luo, C. and Hogan, P. G., Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997. 15: 707-747.
8. Jain, J., Loh, C. and Rao, A., Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 1995. 7: 333-342.
9. Freeman, G. J., Lombard, D. B., Gimmi, C. D., Brod, S. A., Lee, K., Laning, J. C., Hafler, D. A., Dorf, M. E., Gray, G. S., Reiser, H., June, C. H., Thompson, C. B. and Nadler, L. M., CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 1992. 149: 3795-3801.
10. Brunet, J. F., Denizot, F., Luciani, M. F., Roux-Dosseto, M., Suzan, M., Mattei, M. G. and Golstein, P., A new member of the immunoglobulin superfamily -CTLA-4. Nature 1987. 328: 267-270.
11. Alegre, M. L., Noel, P. J., Eisfelder, B. J., Chuang, E., Clark, M. R., Reiner, S. L. and Thompson, C. B., Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J. Immunol. 1996. 157: 4762-4770.
12. Perkins, D., Wang, Z., Donovan, C., He, H., Mark, D., Guan, G., Wang, Y., Walunas, T., Bluestone, J. and Listman, J. et al., Regulation of CTLA-4 expression during T cell activation. J. Immunol. 1996. 156: 4154-4159.
13. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A., CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994. 1: 405-413.
14. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A., CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 1996. 183: 2541-2550.
15. Krummel, M. F. and Allison, J. P., CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 1995. 182: 459-465.
16. Krummel, M. F. and Allison, J. P., CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996. 183: 2533-2540.
17. Van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P. and Davis, S. J., CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J. Exp. Med. 1997. 185: 393-403.
18. Fallarino, F., Fields, P. E. and Gajewski, T. F., B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 1998. 188: 205-210.
19. Lin, H., Rathmell, J. C., Gray, G. S., Thompson, C. B., Leiden, J. M. and Alegre, M.-L., Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J. Exp. Med. 1998. 188: 199-205.
20. Rincón, M. and Flavell, R. A., AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 1994. 13: 4370-4381.
21. + T helper 2 (Th2) cells but not in Th1 cells. Mol. Cell. Biol. 1997. 17: 1522-1534.
22. + T-cells into effector cells. Biochem. Soc. Trans. 1997. 25: 347-354.
23. Rincón, M. and Flavell, R. A., Regulation of AP-1 and NFAT transcription factors during thymic selection of T cells. Mol. Cell. Biol. 1996. 16: 1074-1084.
24. + T cells into effector Th1 and Th2 cells. Genes Function 1997. 1: 51-68.
25. Dariavach, P., Mattei, M. G., Golstein, P. and Lefranc, M. P., Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J. Immunol. 1988. 18: 1901-1905.
26. Oaks, M. K., Penwell, R. T. and Tector, A. J., Nucleotide sequence of the ACI rat CTLA-4 molecule. Immunogenetics 1996. 43: 173-174.
27. Schneider, H., Prasad, K. V., Shoelson, S. E. and Rudd, C. E., CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 1995. 181: 351-355.
28. Marengere, L. E., Water-house, P., Duncan, G. S., Mittrucker, H. W., Feng, G. S. and Mak, T. W., Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996. 272: 1170-1173.
29. 2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J. Exp. Med. 1997. 186: 1645-1653.
30. Su, B., Jacinto, E., Hibi, M., Kallunki, T., Karin, M. and Ben-Neriah, Y., JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994. 77: 727-736.
31. Tugores, A., Alonso, M. A., Sanchez-Madrid, F. and de Landazuri, M. O., Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1. J. Immunol. 1992. 148: 2300-2306.
32. Schreiber, E., Matthias, P., Muller, M. M. and Shaffner, W., Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989. 17: 6419.